Current Clinical Trials
The Metro Research Center is currently enrolling study participants for a number of clinical trials. Click on an individual study below to learn more.
Gilead Oral Remdesivir Clinical Trial
Summary: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral
Remdesivir for the Treatment of COVID-19 in Non-hospitalized Participants
Total Visits: 7 office visits in Burr Ridge, 3 remote visits via telephone
Compensation: Patients will be compensated to be in this study.
Requirements: Within 3 days of symptoms at time of first visit
Infectivity Clinical Trial
Summary: A study evaluating the infectivity levels of those receiving Paxlovid versus no therapy.
Total Visits: 7-12 total visits in person, and 2 remote telephone visits
Compensation: Patients will be compensated to be in this study.
Requirements: Within 3 days of symptoms at time of first visit; within 1 day of starting Paxlovid; positive covid test
